Drug Prices Drop as Companies Trade Off | Business and Finance News

Drug prices are shifting as nearly a dozen major pharmaceutical companies prepare to sign deals to lower costs—part of a broader effort to align U.S. pricing with other developed nations. Building on last year’s 17-company pact including Pfizer and Eli Lilly, this new push targets outpatient drugs for Medicaid, offering discounts in exchange for exemption from Medicare discount programs. While elections loom and healthcare affordability remains a hot topic, the real impact on patient out-of-pocket costs is still unclear. For drugmakers, this move threatens profits despite their investments in domestic manufacturing and direct sales—potentially taking time to balance the financial hit with increased volume. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/6e8ff7e59bc35923